ErVimmune | $19,917,795 | (Jan 21, 2026)
Statusphere | $18,000,000 | (Jan 21, 2026)
Think Bioscience | $55,000,000 | (Jan 21, 2026)
Certified by Founder
Lodge
AllRock Bio
start up
United States
- Natick, Massachusetts
- 17/09/2025
- Series A
- $50,000,000
We’re dedicated to advancing novel therapies to improve the lives of patients suffering from pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions
- Industry Biotechnology Research
- Website https://allrockbio.com/
- LinkedIn https://www.linkedin.com/company/allrock-bio/
POINT.LAZ | $3,000,000 | (Jan 21, 2026)
Jetson(CANADA) | $50,000,000 | (Jan 21, 2026)
BrightInsight | $13,000,000 | (Jan 21, 2026)
Formulary Financial | $4,600,000 | (Jan 21, 2026)
Ultra Pouches | $11,000,000 | (Jan 21, 2026)
XBuild | $19,000,000 | (Jan 21, 2026)
Dam Secure | $4,000,000 | (Jan 21, 2026)
Infinitopes | $15,400,000 | (Jan 21, 2026)
Cosmos | $15,000,000 | (Jan 21, 2026)